Keyphrases
Endometrial Adenocarcinoma
100%
Loss of Heterozygosity
100%
Tumor
88%
Usual Type
55%
Endometrial Cancer
33%
Estrogen
22%
Tumor Subtype
22%
Molecular Genetics
11%
Genetic Modification
11%
Endometrial Carcinoma
11%
Gene-gene
11%
Female Genital Tract
11%
Gene mutation
11%
Low Incidence
11%
Polymerase Chain Reaction
11%
Chromosome 2
11%
Chromosome 12
11%
Polymorphic Loci
11%
Gene Activation
11%
Microsatellite Loci
11%
Molecular Events
11%
Chromosome 17
11%
Chromosome 13
11%
High Loss
11%
Southern Blot Analysis
11%
Chromosome 14
11%
Human Malignancies
11%
Tumor DNA
11%
Genetic Events
11%
Tumorigenic Pathway
11%
Invasive Malignancy
11%
Microsatellite Instability-high (MSI-H)
11%
Contrast Loss
11%
Medicine and Dentistry
Endometrium
100%
Carcinoma
100%
Heterozygosity
100%
Tumor
88%
Neoplasm
33%
Cancer
33%
Gene Mutation
22%
Uterine Cancer
22%
Malignant Neoplasm
11%
Endometrium Carcinoma
11%
Chromosome 12
11%
Chromosome 2
11%
Gene Activation
11%
Southern Blotting
11%
Chromosome 14
11%
Chromosome 17
11%
Chromosome 17p
11%
Chromosome 13
11%
Polymorphic Locus
11%
Microsatellite Instability
11%
Polymerase Chain Reaction
11%
Biochemistry, Genetics and Molecular Biology
Loss of Heterozygosity
100%
Endometrium
100%
Gene Mutation
22%
Molecular Genetics
11%
Microsatellite Instability
11%
Chromosome 12
11%
Chromosome 2
11%
Polymorphic Locus
11%
Gene Activation
11%
Southern Blotting
11%
Chromosome 17
11%
Chromosome 13
11%
Chromosome 14
11%
Chromosome 17p
11%
Polymerase Chain Reaction
11%
Microsatellite
11%